Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2016-09-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.201604-0686OCPMID 27611637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute Respiratory Distress Syndrome

  2016influential reference
• Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation?

  2016cited by this paper
• Effects of Volatile Anesthetics on Mortality and Postoperative Pulmonary and Other Complications in Patients Undergoing Surgery: A Systematic Review and Meta-analysis

  2016cited by this paper
• Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

  2016cited by this paper
• Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome.

  2015cited by this paper
• A pharmacokinetic study of 48-hour sevoflurane inhalation using a disposable delivery system (AnaConDa®) in ICU patients.

  2014influential reference
• Sevoflurane therapy for life-threatening acute severe asthma: a case report

  2014cited by this paper
• Anaesthetic conserving device AnaConDa: dead space effect and significance for lung protective ventilation.

  2014cited by this paper
• Impact of the Anesthetic Conserving Device on Respiratory Parameters and Work of Breathing in Critically Ill Patients under Light Sedation with Sevoflurane

  2014cited by this paper
• Apparent Dead Space with the Anesthetic Conserving Device, AnaConDa®: A Clinical and Laboratory Investigation

  2013cited by this paper
• Sevoflurane therapy for life-threatening asthma in children.

  2013cited by this paper
• Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: A randomised laboratory study

  2013cited by this paper
• Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome

  2013cited by this paper
• Acute Respiratory Distress Syndrome The Berlin Definition

  2012cited by this paper
• The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome

  2012cited by this paper
• Inhalational sevoflurane in severe bronchial obstruction unresponsive to multipharmacologic therapy: a case report

  2012cited by this paper
• Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury

  2012cited by this paper
• Efficiency and safety of inhalative sedation with sevoflurane in comparison to an intravenous sedation concept with propofol in intensive care patients: study protocol for a randomized controlled trial

  2012cited by this paper
• Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema

  2012influential reference
• Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients*

  2011influential reference
• [Efficacy, safety and cost of sedation with sevoflurane in intensive care unit].

  2011cited by this paper
• Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam

  2011cited by this paper
• Efficacité, tolérance et coût d’une sédation par sévoflurane en réanimation

  2011cited by this paper
• Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients.

  2010cited by this paper
• Neuromuscular blockers in early acute respiratory distress syndrome.

  2010cited by this paper
• Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury.

  2009cited by this paper
• Sevoflurane Ameliorates Gas Exchange and Attenuates Lung Damage in Experimental Lipopolysaccharide-induced Lung Injury

  2009cited by this paper
• The volatile anaesthetic sevoflurane attenuates lipopolysaccharide‐induced injury in alveolar macrophages

  2009cited by this paper
• Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support

  2009cited by this paper
• Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs.

  2009cited by this paper
• Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion.

  2009cited by this paper
• State of the art: sedation concepts with volatile anesthetics in critically Ill patients.

  2009cited by this paper
• Anesthetic-induced Improvement of the Inflammatory Response to One-lung Ventilation

  2009cited by this paper
• Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology.

  2008cited by this paper
• Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

  2008cited by this paper
• The Immunomodulatory Effect of Sevoflurane in Endotoxin-Injured Alveolar Epithelial Cells

  2007cited by this paper
• Weaning from mechanical ventilation

  2007cited by this paper
• Comparison of two fluid-management strategies in acute lung injury, H.P. Wiedemann, A.P. Wheeler, G.R. Bernard, B.T. Thompson, D. Hayden, B. deBoisblanc, A.F Jr. Connors, R.D. Hite, A.L. Harabin, in: N Engl J Med, 354. (2006), 2564

  2007cited by this paper
• Comparison of two fluid-management strategies in acute lung injury.

  2006cited by this paper
• Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.

  2006cited by this paper
• Weaning from mechanical ventilation

  2005cited by this paper
• Understanding RAGE, the receptor for advanced glycation end products

  2005cited by this paper
• Receptor for advanced glycation end‐products is a marker of type I lung alveolar cells

  2004cited by this paper
• Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome*

  2004cited by this paper
• Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.

  2003cited by this paper
• Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome.

  2001influential reference
• Sub-MAC concentrations of desflurane do not inhibit hypoxic pulmonary vasoconstriction in anesthetized piglets

  2001cited by this paper
• The acute respiratory distress syndrome.

  2000cited by this paper
• Effects of sevoflurane on hypoxic pulmonary vasoconstriction in anaesthetized piglets.

  2000cited by this paper
• Detecting Alveolar Epithelial Injury following Volatile Anesthetics by 99mTc DTPA Radioaerosol Inhalation Lung Scan

  1999cited by this paper
• Halothane and Isoflurane Decrease Alveolar Epithelial Fluid Clearance in Rats

  1998cited by this paper
• Desflurane Inhibits Hypoxic Pulmonary Vasoconstriction in Isolated Rabbit Lungs

  1995cited by this paper
• Effects of Halothane on Surfactant Biosynthesis by Rat Alveolar Type II Cells in Primary Culture

  1994cited by this paper
• Clinical Comparison of Sevoflurane and Isoflurane in Healthy Patients

  1992cited by this paper
• Pulmonary clearance of 99mTc‐DTPA during halothane anaesthesia

  1990cited by this paper

• Sindrome da distress respiratorio acuto

  2025cites this paper
• Evaluating sedation strategies in acute respiratory distress syndrome: A meta-analysis of inhaled versus intravenous agents.

  2025cites this paper
• Renal Impact of Prolonged Sevoflurane Sedation in Intensive Care Unit Patients: An Observational Study.

  2025cites this paper
• Mise au point : que disent les dernières recommandations européennes sur le SDRA ?

  2025cites this paper
• Inhalational Agents as Intensive Care Unit Sedatives.

  2025cites this paper
• Sedating with volatile anaesthetics for COVID-19 and non-COVID-19 acute hypoxaemic respiratory failure patients in ICU (SAVE-ICU): protocol for a randomised clinical trial

  2025cites this paper
• Prolonged in vitro anti-bacterial, anti-inflammatory, and surfactant-promoting effects of volatile anesthetics

  2025cites this paper
• Prognostic impact of angiotensin-converting enzyme inhibitors and dexmedetomidine in acute respiratory distress syndrome: a MIMIC-IV-based retrospective cohort analysis

  2025cites this paper
• Volatile sedation in critically ills adults undergoing mechanical ventilation: not all inhaled sedatives are equivalent!

  2025cites this paper
• Traumatic Hemorrhagic Lung Injury With Pelvic and Femur Fractures Requiring Resuscitative Balloon Occlusion of the Aorta, Operative Fixation on Dual-Circuit Venous Extracorporeal Membrane Oxygenation, and Systemic Isoflurane Sedation.

  2025cites this paper
• Volatile anesthetics in the intensive care unit

  2025cites this paper
• Effect of Inhaled Volatile and IV Anesthetics on Biological Markers of Inflammation in Adult ICU and Thoracic Surgical Patients: A Systematic Review and Meta-Analysis

  2025cites this paper
• Effects of Sevoflurane Inhalation on Pulmonary Hemodynamics in Moderate to Severe Acute Respiratory Distress Syndrome Patients With Septic Shock: A Prospective Cohort Study.

  2025cites this paper
• Volatile sedation in critically ill adults undergoing mechanical ventilation: a meta-analysis of randomized controlled trials

  2025influential citation
• Inhaled sedation versus propofol in respiratory failure in the ICU (INSPiRE-ICU2): study protocol for a multicenter randomized controlled trial

  2025cites this paper
• Inhaled Sedation in Acute Respiratory Distress Syndrome: The SESAR Randomized Clinical Trial.

  2025cites this paper
• Sevoflurane Sedation in Acute Respiratory Distress Syndrome: Time to Put It to Sleep.

  2025cites this paper
• Safety and effectiveness of inhaled sedation in critically ill patients: a systematic review and meta-analysis

  2025cites this paper
• Safe use of inhaled sedation in critically ill patients with invasive mechanical ventilation.

  2025cites this paper
• Síndrome de dificultad respiratoria aguda

  2025cites this paper
• Long term outcome in patients treated with veno-venous extracorporeal membrane oxygenation: A prospective observational study.

  2024cites this paper
• Syndrome de détresse respiratoire aiguë

  2024cites this paper
• Management of pain and sedation in the intensive care unit

  2024cites this paper
• INhaled Sedation versus Propofol in REspiratory failure in the Intensive Care Unit (INSPiRE-ICU1): protocol for a randomised, controlled trial

  2024cites this paper
• Anesthetic Gas Scavenging System for Gas Evacuation in the ICU

  2024cites this paper
• Impact of inhaled sedation on delirium incidence and neurological outcome after cardiac arrest - a propensity-matched control study (Isocare).

  2024cites this paper
• Anesthésiste donc réanimateur.trice, gage de qualité des soins en France

  2024cites this paper
• Effects of inhalation versus total intravenous anaesthesia on long-term mortality in older patients after noncardiac surgery: a retrospective observational study.

  2024cites this paper
• Uso seguro de la sedación inhalada en pacientes críticos sometidos a ventilación mecánica invasiva

  2024cites this paper
• Early and late effects of volatile sedation with sevoflurane on respiratory mechanics of critically ill COPD patients

  2024cites this paper
• Practical approach to inhaled sedation in the critically ill patient. Sedation, analgesia and Delirium Working Group (GTSAD) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).

  2024cites this paper
• Volatile Anesthetic Sedation for Critically Ill Patients

  2024cites this paper
• Abordaje práctico de la sedación inhalada en el paciente crítico. Grupo de Trabajo de Sedación, Analgesia y Delirium (GTSAD) de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC)

  2024cites this paper
• Sedation modality in acute respiratory distress syndrome: does method of sedation affect length of stay, outcomes, or adverse events? A systematic review

  2024cites this paper
• Volatile sedation practices in patients with severe acute respiratory distress syndrome under VV-ECMO support

  2024cites this paper
• Effects of sevoflurane on lung alveolar epithelial wound healing and survival in a sterile in vitro model of acute respiratory distress syndrome.

  2024cites this paper
• Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial

  2024cites this paper
• Influence of Sevoflurane on the Neurological Pupil Index in Surgical and Critically Ill Patients: A Pilot Study

  2024cites this paper
• Inhaled Volatiles for Status Asthmaticus, Epilepsy, and Difficult Sedation in Adult ICU and PICU: A Systematic Review

  2024cites this paper
• Guidelines for inhaled sedation in the ICU.

  2024cites this paper
• Effects on mechanical power of different devices used for inhaled sedation in a bench model of protective ventilation in ICU

  2024influential citation
• Prolonged sedation with sevoflurane in comparison to intravenous sedation in critically ill patients - A randomized controlled trial.

  2023cites this paper
• Inhaled Sedation with Volatile Anesthetics for Mechanically Ventilated Patients in Intensive Care Units: A Narrative Review

  2023cites this paper
• An in-silico porcine model of phosgene-induced lung injury predicts clinically relevant benefits from application of continuous positive airway pressure up to 8 h post exposure.

  2023cites this paper
• Pro-Con Debate: Should All General Anesthesia Be Done Using Target-Controlled Propofol Infusion Guided by Objective Monitoring of Depth of Anesthesia?

  2023cites this paper
• Sedation for Patients with Sepsis: Towards a Personalised Approach

  2023cites this paper
• Guía de sedación inhalada en la UCI

  2023cites this paper
• The advantages of inhalational sedation using an anesthetic-conserving device versus intravenous sedatives in an intensive care unit setting: A systematic review

  2023cites this paper
• Diabetes insipidus renalis nach inhalativer Sedierung mit Sevofluran bei einem Patienten mit COVID-19-assoziiertem akuten Lungenversagen

  2023cites this paper
• Sevoflurane sedation in COVID-19 acute respiratory distress syndrome: an observational study with a propensity score matching model

  2023cites this paper
• Inhaled anesthetic sedation, an alternative to the scarcity of traditional sedatives: a case report

  2023cites this paper
• Experiencia y revisión de la literatura del uso del dispositivo Anesthetic Conserving Device (AnaConDa) durante la pandemia en pacientes con neumonía por COVID-19 en un hospital público

  2023cites this paper
• Improved understanding of the respiratory drive pathophysiology could lead to earlier spontaneous breathing in severe acute respiratory distress syndrome

  2023cites this paper
• Renal safety of critical care sedation with sevoflurane: a systematic review and meta-analysis

  2023influential citation
• Halogenated volatile anaesthetics for prolonged sedation in pediatric intensive care unit: first experience in two French pediatric intensive care units

  2023cites this paper
• Author's response: Prolonged sedation with sevoflurane in comparison to intravenous sedation in critically ill patients - A randomized controlled trial.

  2023cites this paper
• Effect of inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: a systematic review and meta-analysis.

  2023cites this paper
• Effects of sevoflurane on lung epithelial permeability in experimental models of acute respiratory distress syndrome

  2023influential citation
• Sedation with Sevoflurane versus Propofol in COVID-19 Patients with Acute Respiratory Distress Syndrome: Results from a Randomized Clinical Trial

  2023cites this paper
• Sedation with volatile anesthetics in the intensive care unit: a new option with old agents

  2023cites this paper
• Ventilatory Effects of Isoflurane Sedation via the Sedaconda ACD-S versus ACD-L: A Substudy of a Randomized Trial

  2023cites this paper
• Patient Self-Inflicted Lung Injury—A Narrative Review of Pathophysiology, Early Recognition, and Management Options

  2023cites this paper
• Inhaled volatile anesthetics in the intensive care unit

  2023cites this paper
• Sedación inhalada en la unidad de cuidados intensivos

  2023cites this paper
• The oxygen dissociation curve of blood in COVID-19–An update

  2023cites this paper
• Usefulness of Inhaled Sedation in Patients With Severe ARDS Due to COVID-19

  2023cites this paper
• Sevoflurane anesthesia ameliorates LPS-induced acute lung injury (ALI) by modulating a novel LncRNA LINC00839/miR-223/NLRP3 axis

  2022cites this paper
• Analgesia y sedación en cuidados intensivos (reanimación) en el paciente adulto

  2022cites this paper
• Effect of sedation with inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: a systematic review protocol

  2022cites this paper
• Analgesia-sedazione in terapia intensiva (rianimazione) negli adulti

  2022cites this paper
• Intensive care nurses' experiences using volatile anaesthetics in the intensive care unit: An exploratory study.

  2022cites this paper
• Towards a biological definition of ARDS: are treatable traits the solution?

  2022cites this paper
• Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1

  2022cites this paper
• Sevoflurane in combination with esketamine is an effective sedation regimen in COVID-19 patients enabling assisted spontaneous breathing even during prone positioning

  2022cites this paper
• Anesthetics to Prevent Lung Injury in Cardiac Surgery: A Randomized Controlled Trial.

  2022cites this paper
• Inhaled Sedation for Invasively Ventilated COVID-19 Patients: A Systematic Review

  2022cites this paper
• Inhaled Sedation in Patients with COVID-19-Related Acute Respiratory Distress Syndrome: An International Retrospective Study

  2022cites this paper
• Halogenated anesthetics vs intravenous hypnotics for short and long term sedation in the intensive care unit: A meta-analysis.

  2022cites this paper
• Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial

  2022cites this paper
• Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics

  2022cites this paper
• Sédation en réanimation

  2022cites this paper
• Inhaled sedation in the intensive care unit.

  2022cites this paper
• Volatile anesthetics for ICU sedation: the future of critical care or niche therapy?

  2022cites this paper
• Druggable targets and therapeutic development for COVID-19

  2022cites this paper
• Lung-protective sedation: moving toward a new paradigm of precision sedation

  2022cites this paper
• Isoflurane vs. propofol for sedation in invasively ventilated patients with acute hypoxemic respiratory failure: an a priori hypothesis substudy of a randomized controlled trial

  2022influential citation
• The impact of the coronavirus pandemic on sedation in critical care: volatile anesthetics in the ICU

  2022cites this paper
• Use of volatile anesthetics for sedation in the ICU during the COVID-19 pandemic: A national survey in France (VOL’ICU 2 study)

  2022cites this paper
• Effects of sevoflurane and its metabolite hexafluoroisopropanol on hypoxia/reoxygenation-induced injury and mitochondrial bioenergetics in murine cardiomyocytes

  2022cites this paper
• The oxygen dissociation curve of blood in COVID-19

  2021cites this paper
• Intérêt du sévoflurane pour la sédation en réanimation

  2021cites this paper
• Invasive Mechanical Ventilation of COVID-19 ARDS Patients

  2021cites this paper
• Sevoflurane prevents pulmonary vascular remodeling and right ventricular dysfunction in pulmonary arterial hypertension in rats.

  2021cites this paper
• Analgésie-sédation en soins critiques (réanimation) chez l’adulte

  2021cites this paper
• The Characterization of Postoperative Mechanical Respiratory Requirement in Neonates and Infants Undergoing Cardiac Surgery on Cardiopulmonary Bypass in a Single Tertiary Institution.

  2021cites this paper
• Extracorporeal membrane oxygenation and inhaled sedation in coronavirus disease 2019-related acute respiratory distress syndrome

  2021cites this paper
• TIVA versus Inhalational Agents for Pediatric Cardiac Intensive Care

  2021cites this paper
• Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 patients

  2021cites this paper
• Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients—a retrospective chart review

  2021cites this paper
• Complicanze respiratorie postoperatorie

  2021cites this paper